Search Results - "Ojalvo, Ariana G"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Expression of cell proliferation cycle negative regulators in fibroblasts of an ischemic diabetic foot ulcer. A clinical case report by Berlanga‐Acosta, Jorge, Mendoza‐Mari, Yssel, Martínez, María Daniela, Valdés‐Perez, Calixto, Ojalvo, Ariana G, Armstrong, David G

    Published in International wound journal (01-04-2013)
    “…Wound chronification and opportunistic infections stand as major factors leading to lower extremities amputations in diabetes. The molecular mechanisms…”
    Get full text
    Journal Article
  2. 2

    A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic by Torrèns, Isis, Ojalvo, Ariana G, Seralena, Alina, Hayes, Orlando, de la Fuente, Josè

    Published in Immunology letters (01-12-1999)
    “…Streptokinase (SK) is the most widely used compound for the treatment of myocardial infarction and the least expensive thrombolytic agent, but a drawback to…”
    Get full text
    Journal Article
  3. 3

    Prevalence of Circulating Antibodies against a Streptokinase C-Terminal Peptide in Normal Blood Donors by Ojalvo, Ariana G., Pozo, Lilliam, Labarta, Violeta, Torréns, Isis

    “…Streptokinase (SK) is a streptococcal protein widely used as a thrombolytic agent. Anti-SK antibodies (Abs) are found in most individuals due to common…”
    Get full text
    Journal Article
  4. 4

    Mapping of the Antigenic Regions of Streptokinase in Humans after Streptokinase Therapy by Torréns, Isis, Reyes, Osvaldo, Ojalvo, Ariana G., Seralena, Alina, Chinea, Glay, Cruz, Luis J., de la Fuente, José

    “…Streptokinase (SK) is efficaciously used as a thrombolytic drug for the treatment of myocardial infarction. Being a bacterial protein, SK is immunogenic in…”
    Get full text
    Journal Article
  5. 5

    A Mutant Streptokinase Lacking the C-Terminal 42 Amino Acids Is Less Reactive with Preexisting Antibodies in Patient Sera by Torréns, Isis, Ojalvo, Ariana G., Seralena, Alina, Pupo, Elder, Lugo, Victoria, Páez, Rolando

    “…Streptokinase (SK) is an efficacious thrombolytic drug for the treatment of myocardial infarction. Because of its immunogenicity, patients receiving SK therapy…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12